| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |